{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"#8 - Dr. Angela Reiersen: Depression, the Sigma 1 receptor and COVID-19","description":"In this episode I speak with Psychiatrist and researcher Dr. Angela Reiersen about her recent publication in JAMA, &quot;Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19.&quot; We discuss:&amp;nbsp; -How she stays focused and gets things done -Her research on fluvoxamine (an antidepressant) and COVID-19 -Why we need to go beyond the serotonin receptor in depression -What the sigma 1 receptor is, and why it matters -How sigma 1 agonists may reduce inflammation -The need for a wider view of antidepressant mechanisms -The importance of the connection between inflammation and depression -How understanding newmolecular patterns of depression opens the door to treatment -The importance of executive function interventions for children -How sleep may improve executive functions ","author_name":"Get the STUCK Out","author_url":"http:\/\/getthestuckout.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/17713838\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/94460741"}